Immunotherapy for breast cancer in India typically costs from AUD $4,045 to AUD $10,402. Prices depend on the specific drug, dosage, and diagnostic tests like PD-L1 markers. In Australia, patients often face costs around AUD $15,458 for similar private treatments. By choosing India, Australians can save approximately 53%. This treatment typically includes drug administration, nursing care, and oncology consultations at major medical hubs like Mumbai, Bengaluru, and Gurgaon.
Bookimed Expert Insight: Choosing large network hospitals provides significant value through advanced planning tools. For instance, Manipal Goa Hospital uses IBM Watson for oncology to refine treatment protocols. Additionally, specialists like Dr. Shruti Kate at HCG Manavata Cancer Centre bring experience from Tata Memorial Hospital. This level of expertise is accessible at a fraction of Australian private healthcare rates.
| India | Thailand | Turkey | |
| Immunotherapy for breast cancer | from AUD $4,045 | from AUD $21,670 | from AUD $13,724 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy for breast cancer upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy for breast cancer and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy for breast cancer journey.
The doctor graduated with a Bachelor of Medicine from Mysore University in 1996, followed by a Doctor of Medicine in radiotherapy from Banaras Hindu University in 2002. Further enhancing expertise, the doctor earned a Diplomate of National Board in radiotherapy in 2004.
The doctor is a member of several prestigious organizations, including the Association of Radiation Oncology of India, the Society for Neuro-Oncology, the Bangalore Oncology Group, and the Indian Association of Hyperthermia Oncology, reflecting a strong commitment to advancing the field of oncology.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
Dr Shruti Kate leads the medical oncology department at HCG Manavata Cancer Centre. She previously served as a consultant at Tata Memorial Hospital, focusing on immunotherapy for advanced breast and lung malignancies.
Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.